Document -
Strategic Investment by JSR in Biopharmaceutical Purification Technologies
Tokyo, Japan, February 14, 2013 - JSR Corporation (President: Mitsunobu Koshiba) has signed a strategic partnership agreement with ChromaCon AG (headquartered in Zurich, Switzerland), a private company providing biopharmaceutical purification process technologies.
See http://www.jsrlifesciences.com/jsr_e/news/20130214.shtml
-
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format: .pdf
